| Intra-vascular large B-cell lymphoma revealed by a nephrotic syndrome: a one year remission induced by a high frequency CHOP and rituximab. | |
| | |
MedLine Citation:
|
PMID: 15370230 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Intra-vascular lymphoma is usually reported as a rare and fatal disorder. We describe here the first case of an intra-vascular lymphoma revealed by a nephrotic syndrome for which a durable remission has been obtained by 8 cycles of bi-mensual CHOP and Rituximab therapy. In this report, 18 fluorodesoxyglucose tomoscintigraphy is discussed as a tool for intra-vascular lymphoma extension and follow-up. |
| | |
Authors:
|
T Girard; D Nochy; F Montravers; G Der Sahakian; R Fior; P Galanaud; F Boué |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Leukemia & lymphoma Volume: 45 ISSN: 1042-8194 ISO Abbreviation: Leuk. Lymphoma Publication Date: 2004 Aug |
Date Detail:
|
Created Date: 2004-09-29 Completed Date: 2004-12-21 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9007422 Medline TA: Leuk Lymphoma Country: England |
Other Details:
|
Languages: eng Pagination: 1703-5 Citation Subset: IM |
Affiliation:
|
Service de Medecine Interne, Hôpital Antoine Béclère, Faculté de Médecine Paris-Sud, Paris, France. thomas.girard@bch.ap-hop-paris.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Antibodies, Monoclonal / therapeutic use* Antineoplastic Agents / therapeutic use* Antineoplastic Combined Chemotherapy Protocols / therapeutic use* Cyclophosphamide / therapeutic use* Doxorubicin / therapeutic use* Female Humans Lymphoma, B-Cell / drug therapy*, pathology Lymphoma, Large B-Cell, Diffuse / drug therapy*, pathology Nephrotic Syndrome / pathology* Prednisone / therapeutic use* Remission Induction Tomography, Emission-Computed, Single-Photon Vascular Neoplasms / drug therapy*, pathology Vincristine / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Antineoplastic Agents; 0/CHOP protocol; 0/rituximab; 23214-92-8/Doxorubicin; 50-18-0/Cyclophosphamide; 53-03-2/Prednisone; 57-22-7/Vincristine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: MALT lymphoma of the foreskin.
Next Document: Eosinophilic fasciitis after allogeneic stem cell transplantation: a case report and review of the l...